![FDA, FTC and DOJ Enforcement of Medical Device Regulations FDA, FTC and DOJ Enforcement of Medical Device Regulations](https://www.fdanews.com/ext/resources/Book-Covers-2/BFFDEMDR-COVER.png?height=200&t=1685733565&width=200)
Home » NATCO PHARMA LAUNCHES BORTEZOMIB INJECTION
NATCO PHARMA LAUNCHES BORTEZOMIB INJECTION
Natco Pharma Ltd on Wednesday launched brand Bortenat, used in the treatment of plasma cell cancer, in injection form. The Economic Times (http://economictimes.indiatimes.com/articleshow/1923370.cms)
KEYWORDS Daily International Pharma Alert
Upcoming Events
-
21Oct